U.S. Geological Survey science strategy to address highly pathogenic avian influenza and its effects on wildlife health 2025–29

Executive Summary

Highly pathogenic avian influenza (HPAI) is an ecologically and economically important animal disease that can also directly affect humans (a “zoonotic” disease). HPAI was once limited almost exclusively to domestic poultry but has rapidly adapted to diverse animal hosts. Viruses causing HPAI now appear to be maintained and dispersed by wild birds largely independent of poultry, though HPAI continues to cause considerable economic losses and supply chain disruptions in the domestic poultry trade. Coincident with the adaptation of HPAI viruses to wild birds, particularly waterfowl and gulls, increasingly diverse wild bird hosts are becoming exposed to HPAI, often resulting in disease and death. More sporadically, HPAI has caused mass mortality events, particularly among seabirds. Furthermore, viral spillover to wild and domestic mammals has become more common. Spillover to wild mammals has resulted in mortality among diverse terrestrial and marine taxa, including episodic losses of such scale as to represent potential conservation challenges. Since approximately March 2024, HPAI has also affected dairy cows, which represents a new threat to the agricultural economy. Lastly, HPAI has increasingly affected humans through domestic animal exposures, exemplifying the considerable implications of this disease beyond animal health.

Rapid changes in the ecology of HPAI are currently outpacing research efforts. For example, it is not entirely clear which newly established hosts may become reservoirs for HPAI viruses (in other words, capable of maintaining HPAI viruses within a broad population indefinitely) and how this may influence viral evolution and dissemination. As a result, there are considerable information gaps regarding HPAI in wildlife that, if filled, would improve the ability of scientists, managers, agricultural industry representatives, and healthcare professionals to understand and to anticipate the effects of HPAI on wild animal, domestic animal, environmental, and human health (“One Health”).

The U.S. Geological Survey (USGS) is the lead Federal agency providing scientific research on avian influenza viruses (AIVs), including HPAI viruses, that affect wildlife for which the Department of the Interior (DOI) has management authority. States have jurisdiction over wildlife on Federal lands within their borders (43 CFR § 24.3), so the USGS Ecosystems Mission Area (EMA) coordinates with State natural resource management agencies. The EMA focuses its research on HPAI through priorities identified by the USGS Avian Influenza Science Team (app. 1). Priorities identified by the USGS Avian Influenza Science Team are based on Administration priorities, Congressional direction, and discussions with State, Federal, and Tribal natural resource management agencies that identify specific scientific gaps that need to be filled to inform sound wildlife management decisions. Notable non-DOI Federal partners include the U.S. Department of Agriculture, the lead for the HPAI regulatory response in poultry and livestock, and the Centers for Disease Control and Prevention (CDC), the lead agency for the HPAI response pertaining to human health.

The USGS offers unique expertise and capacity pertaining to research on diseases affecting free-ranging wildlife populations. This expertise has been critical to interjurisdictional surveillance and capacity-building efforts, including programs administered by the U.S. Department of Agriculture and the CDC. The USGS also provides resources, guidance, and tools to inform surveillance and interventions conducted by natural resource management agencies. More specifically, the USGS EMA provides objective and rigorous scientific data for inferring (1) the utility of new methods to detect and characterize AIVs, including those maintained in wildlife and the environment; (2) effects of HPAI on wildlife; (3) spatiotemporal patterns of wildlife host and AIV dispersal; (4) the presence and persistence of AIVs in the environment; (5) how HPAI in wildlife influences consumptive and nonconsumptive utilization of wildlife; (6) how new tools and scientific methods may promote sound management decisions for HPAI-affected wildlife, particularly species of conservation concern; and (7) the combined effects of HPAI and other stressors on ecosystem health and resiliency.

This science strategy builds upon research outlined in a previous USGS science strategy for HPAI (2016–20) by Harris and others (2016). This strategy also details research priorities identified by the Administration (for example, U.S. Department of Agriculture, 2025) and others based on USGS Avian Influenza Science Team discussions with natural resource management agencies to address HPAI and wildlife health over the next 5 years (2025–29). This strategy presents 7 goals and 26 objectives that focus USGS and partner efforts on priorities that will fill data gaps regarding the effects of HPAI on wildlife managed by or co-managed with the U.S. Department of the Interior such that agencies and partners might anticipate or limit adverse effects on public resources. This strategy also identifies research priorities intended to address HPAI in wildlife and wildlife habitat that are anticipated to support interjurisdictional One Health efforts.